Skip to content
Lower risk Medical device recall · FDA · Published July 18, 2017

BD MAX Vaginal Panel Recall: Unresolved Test Results Risk Repeat Testing

Becton Dickinson recalls BD MAX Vaginal Panel (catalogs 443712, 443710, 443711) due to increased unresolved and indeterminate test results, potentially requiring repeat testing.

🇺🇸 FDA recall #Z-0392-2018Medical deviceBecton Dickinson ›
Take action

Contact the company

Recalling firmBecton Dickinson & Co.7 Loveton Cir · Sparks, MD 21152-9212
✎ GovInfoNow plain-language explainer

What happened, in plain English

Becton Dickinson is recalling its BD MAX Vaginal Panel because some tests show unresolved or indeterminate results, which may require repeating the test or re-collecting samples. This could lead to delays in diagnosis and treatment. Read more at govinfonow.com/recall/73399-bd-max-vaginal-panel-recall-unresolved-test-results-risk-repeat.

Source Summary by GovInfoNow · govinfonow.com/recall/73399-bd-max-vaginal-panel-recall-unresolved-test-results-risk-repeat · Updated September 20, 2026 · FDA enforcement record: FDA #Z-0392-2018

Cite this page

“BD MAX Vaginal Panel Recall: Unresolved Test Results Risk Repeat Testing.” GovInfoNow, updated September 20, 2026. https://govinfonow.com/recall/73399-bd-max-vaginal-panel-recall-unresolved-test-results-risk-repeat. Based on FDA recall #Z-0392-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0392-2018%22&limit=1).

Why it’s dangerous

The panel sometimes produces unresolved (UNR) or indeterminate (IND) results, meaning the test doesn't clearly indicate whether a condition is present. This could require repeating the test or re-collecting samples, causing delays in diagnosis.

Who’s affected

Healthcare providers using the BD MAX Vaginal Panel for vaginal and endocervical swab tests are affected. Patients who need this test may face delays in getting results.

How to tell if you have this one

Check for catalog numbers 443712, 443710, or 443711 on the panel. The product is for collection and transport of vaginal and endocervical swab specimens.

  • Brand
    Becton Dickinson
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    US and OUS.
Recall numberProduct, codes & lots
Z-0392-2018BD MAXTM Vaginal Panel. Catalog Number(s): 443712 443710 443711 (RUO)for collection and transport of vaginal and endocervical swab specimens, in addition to the preservation of urine from males and females.; UDI: 30382904433766. All Lot numbers: Not Distributed in US Not Distributed in US
Z-0393-2018BD MAX" UVE Specimen Collection Kit. Catalog Number(s): 443376 for collection and transport of vaginal and endocervical swab specimens, in addition to the preservation of urine from males and females.; UDI: 30382904433766. All Lot numbers: All when used with catalog 443712, 443824 and 442970.
Z-0394-2018BD MAX" CT/GC/TV. Catalog Number(s): 443824,442970,443590 (RUO).for collection and transport of vaginal and endocervical swab specimens, in addition to the preservation of urine from males and females.; UDI: 30382904433766. All Lot numbers: All. All *.Catalog number 442970 was originally distributed in Europe only. Catalog number 443824 was discontinued and replaced with 442970 for US sales. Catalog number 442970 is now distributed worldwide. Not Distributed in US.
Based on the official FDA remedy

What to do — step by step

  1. Check Test Results

    Review test results for unresolved (UNR) or indeterminate (IND) outcomes, which may require repeating the test.

How this recall unfolded

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Jul 18, 201712. FDA classified it Class II: Jan 19, 201823. Published in FDA’s Enforcement Report: Jan 31, 201834. FDA terminated the recall: Jul 9, 2018420172018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0392-2018 (July 18, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0392-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on September 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA